Neuroscience

Disease

Related News

Roche Holding Shares Show Undervaluation Despite Strong Multi-Year Gains

Roche Holding AG shares show potential undervaluation despite strong returns, with DCF models suggesting 59% upside. The pharmaceutical giant trades at P/E ratios below fair value estimates while maintaining solid financial performance and dividend growth. Recent pipeline developments and product innovations support long-term growth prospects.

Related Clinical Trials

NCT ID Title Status Phase
NCT06264063

Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia

COMPLETED NA
NCT06251479

Study of the Dynamics of Verbal and Non-verbal Interaction in Healthy Subjects, Through the Recording of Body Movements and Non-invasive Neurophysiological Techniques

RECRUITING NA
NCT05201534

Interventions in Mathematics and Cognitive Skills

RECRUITING NA
NCT05084300

Effectiveness Pain Neuroscience Education In The Executive Functions In Patients With Fibromyalgia

UNKNOWN NA
NCT03998787

Metabotropic Receptors For Glutamate Type 3 In Parkinson's

UNKNOWN
NCT03781557

Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels

UNKNOWN PHASE4
NCT03324217

Effects of Motor Imagery and Action Observation on Electromyographic Activity and Intramuscular Oxygenation in the Hand Gripping Gesture

COMPLETED NA
NCT01223014

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] AZD2423 in Volunteers

COMPLETED